title: [Sclerotherapy of post-renal transplantation lymphocele with percutaneous instillation of amidotrizoate].
abstract: Incidence of post-renal transplant (RT) lymphocele varies between 0.6% to 41% depending on the author. Therapeutical management of these entities is controversial. (Open or laparoscopic) surgical marsupialization of the peritoneal cavity, percutaneous drainage, and percutaneous sclerosis with povidone-iodine are all valid options to treat post-RT lymphocele. This paper presents two cases of symptomatic post-RT lymphocele not suitable for laparoscopic treatment, which were resolved by intracavitary instillation of Sodium Amidotrizoate 76%. The first case had been previously treated with povidone-iodine with no resolution, also maintaining a 500 ml/24h deficit. In the second case, instillation with Sodium Amidotrizoate 76% was considered first choice approach. In both instances the lymphocele deficit ceased with instillation intervals of 6 and 14 days, respectively. In brief, percutaneous sclerosis with Amidotrizoate can be a valid alternative for the treatment of post-RT lymphocele.
authors.affiliation: Servicio de Urología, Hospital Ramón y Cajal, Madrid.
authors.forename: C
authors.initials: C
authors.lastname: Carrera
authors.forename: F J
authors.initials: FJ
authors.lastname: Burgos
authors.forename: R
authors.initials: R
authors.lastname: Rodríguez
authors.forename: V
authors.initials: V
authors.lastname: Gómez
authors.forename: M
authors.initials: M
authors.lastname: Rivera
mesh_terms: D000328:Adult; D002985:Clinical Protocols; D003973:Diatrizoate / Q000008:administration & dosage*; D006801:Humans; D007322:Instillation, Drug; D016030:Kidney Transplantation / Q000009:adverse effects*; D008210:Lymphocele / Q000209:etiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015911:Sclerotherapy
chemical_list: D003973:Diatrizoate